Medicine and Dentistry
Magnetic Resonance Imaging
100%
Cancer
64%
Positron Emission Tomography-Computed Tomography
59%
Biopsy Technique
40%
Neoplasm
39%
Neuroendocrine Tumor
39%
Diseases
38%
Fluorodeoxyglucose F 18
36%
Pelvis
34%
Radiology
32%
Radioactive Tracer
29%
Positron Emission Tomography - Magnetic Resonance Imaging
29%
Positron Emission Tomography
28%
Fluorodeoxyglucose
25%
Infection
24%
Polyethylene Terephthalate
22%
Thyroid Nodule
21%
Anal Fistula
19%
Pancreas Islet Cell Tumor
19%
Computer Assisted Tomography
19%
Fistula
18%
Kidney Tumour
17%
Bile Duct
17%
Bleeding
17%
Ovarian Tumor
16%
Cholestasis
16%
Cross-Sectional Imaging
15%
Image Quality
15%
Tuberous Sclerosis
15%
Treatment Response
14%
Standardized Uptake Value
13%
Lung Scintiscanning
13%
Echo Contrast Medium
13%
Krukenberg Tumor
13%
Heart Disease
13%
Mammography
13%
Cross Sectional Study
13%
Parathyroid
13%
Magnetic Resonance Cholangiopancreatography
12%
Retrospective Study
10%
Surgical Technique
10%
Multimodality Imaging
10%
Ovarian Cancer
10%
Computed Tomography Angiography
10%
Needle Biopsy
10%
Ischemia
9%
Persistent Truncus Arteriosus
9%
Differential Diagnosis
9%
Pathophysiology
9%
Albumin
9%
Keyphrases
Radiologists
85%
Positron Emission Tomography-computed Tomography (PET-CT)
55%
Ultrasound
36%
Image Features
33%
Pancreatic Neuroendocrine Tumors (pNETs)
32%
Oncologic
31%
PET-MRI
29%
Imaging Findings
29%
Imaging Modalities
27%
Malignancy
26%
Pictorial Review
26%
Data Systems
22%
Tumor
21%
Magnetic Resonance Imaging
20%
Neuroendocrine Neoplasms
20%
SUVmax
20%
Perianal Fistula
19%
Retrospective Analysis
19%
Cross-sectional Imaging
18%
Fistula
18%
Standardized Uptake Value
18%
Incidental
17%
18F-fluorodeoxyglucose (18F-FDG)
16%
Imaging Studies
16%
Computed Tomography
16%
Reporting System
16%
Hepatobiliary
16%
Thyroid Nodule
16%
Kidney
16%
Liver
16%
Image-guided
15%
Treatment-related
15%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
15%
Pathologic Conditions
15%
Bleeding
14%
Imaging Protocol
14%
Pelvis
14%
18F-fluorodeoxyglucose PET
13%
Ultrasound Imaging
13%
18F-fluorodeoxyglucose Uptake
13%
Thyroid Imaging Reporting
13%
Malignant Epithelial Ovarian Tumor
13%
Ultrasound Contrast Agents
13%
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
13%
Complex mutations
13%
Tuberous Sclerosis Complex
13%
TSC mutations
13%
Breast
13%
Well-differentiated Pancreatic Neuroendocrine Tumor
13%
Epithelial Ovarian Cancer
13%